French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in the third quarter, helped by ...

French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in the third quarter, boosted ...

Sanofi is now in “exclusive negotiations ... With the French government saying that it has received assurances from New York City-based CD&R that it will keep Opella’s manufacturing facilities ...

Sanofi (SNYNF) announced it has entered into exclusive negotiations to sell a 50 percent controlling stake in its consumer healthcare ...

POM Investment Strategies LLC acquired a new stake in Sanofi during the second quarter worth approximately $25,000. Register Financial Advisors LLC bought a new position in shares of Sanofi in the ...

Sanofi is aiming to sign an agreement this weekend to sell control of its consumer health business to Clayton Dubilier & Rice, following a last-ditch attempt by a rival bidder to derail the deal ...

MC: There is no old or new model, but there is old school thinking and open school thinking. We are clearly conscious of this within Sanofi and we truly believe that we will overcome the future ...

As BSNL is regaining its lost glory, the state-owned telecom company has introduced its new logo. This has come at a time when the company is preparing to launch its 5G services. BSNL ‘s 4G ...

Sanofi has bolstered the case for its oral BTK inhibitor tolebrutinib as a treatment for multiple sclerosis (MS), due to be filed for approval in the latter half of this year, with new data in a ...

French drugmaker Sanofi's announcement that it will sell a controlling stake in its consumer health division to a U.S. investment fund ignited fresh political backlash on Monday, fueled by concerns ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...